Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Evolving Treatment Landscape of BTK Inhibitors in B-Cell Malignancies
EP. 1: Diagnosing Waldenstrom Macroglobulinemia
March 4th 2019
EP. 2: Genomic Profiling in Chronic Lymphocytic Leukemia
March 4th 2019
EP. 3: Targeting BTK in B-Cell Malignancies
March 4th 2019
EP. 4: BTK Inhibitors Explored in B-Cell Malignancies
March 4th 2019
EP. 5: Resistance to BTK Inhibitors in B-Cell Malignancies
March 4th 2019
EP. 6: BTK Inhibitors in Waldenstrom Macroglobulinemia
March 4th 2019
EP. 7: First-Generation BTK Inhibition in Mantle Cell Lymphoma
March 4th 2019
EP. 8: New and Emerging BTK Inhibitors in Mantle Cell Lymphoma
March 4th 2019
EP. 9: BTK Inhibitors in Chronic Lymphocytic Leukemia
March 4th 2019
EP. 10: BTK Combination Strategies for B-Cell Malignancies
March 4th 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x